CSGP Q2 adj. EPS $0.32 vs. est. $0.29, beat by $0.03; revenue $925Mm, up 18% year over year vs est $928.75Mm; gross profit $728Mm; adj. EBIT
CSGP Q2 adj. EPS $0.32 vs. est. $0.29, beat by $0.03; revenue $925Mm, up 18% year over year vs est $928.75Mm; gross profit $728Mm; adj. EBITDA $184Mm vs est $173.24Mm; Q3 guidance for revenue at $935Mm–$945Mm vs est $967.71Mm and adj. EPS $0.31–$0.34 vs est $0.38, both below consensus, while FY26 guidance is reaffirmed at revenue $3.715B–$3.755B vs est $3.799B and adj. EPS $1.32–$1.39 vs est $1.36 with FY adj. EBITDA guided to $780Mm–$820Mm vs est $807.7Mm; shares -12%
CSGP Q2 adj.
EPS $0.32 vs. est. $0.29, beat by $0.03; revenue $925Mm, up 18% year over year vs est $928.75Mm; gross profit $728Mm; adj.
EBITDA $184Mm vs est $173.24Mm; Q3 guidance for revenue at $935Mm–$945Mm vs est $967.71Mm and adj.
EPS $0.31–$0.34 vs est $0.38, both below consensus, while FY26 guidance is reaffirmed at revenue $3.715B–$3.755B vs est $3.799B and adj.
EPS $1.32–$1.39 vs est $1.36 with FY adj.
EBITDA guided to $780Mm–$820Mm vs est $807.7Mm; shares -12%